These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26249541)

  • 1. Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements.
    Lee KE; Chang BC; Park S; Gwak HS
    Pharmacogenomics; 2015; 16(10):1101-8. PubMed ID: 26249541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
    An SH; Chang BC; Lee KE; Gwak HS
    Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses.
    Chung JE; Lee KE; Chang BC; Gwak HS
    Gene; 2018 Jan; 641():68-73. PubMed ID: 29054760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Pregnane X Receptor Genetic Polymorphisms on Stable Warfarin Doses.
    Moon JY; Chang BC; Lee KE; Bang JS; Gwak HS
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):532-8. PubMed ID: 25848132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves.
    Lee KE; Chung JE; Yi B; Cho YJ; Kim HJ; Lee GY; Kim JH; Chang BC; Gwak HS
    Int J Cardiol; 2017 Jun; 236():393-397. PubMed ID: 28262345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves.
    Chung JE; Chang BC; Lee KE; Kim JH; Gwak HS
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1229-36. PubMed ID: 26257249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients.
    Wattanachai N; Kaewmoongkun S; Pussadhamma B; Makarawate P; Wongvipaporn C; Kiatchoosakun S; Vannaprasaht S; Tassaneeyakul W
    Eur J Clin Pharmacol; 2017 Aug; 73(8):973-980. PubMed ID: 28550460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of
    Li W; Zhao P; Chen L; Lai X; Shi G; Li L; Dong J
    Pharmacogenomics; 2020 Jan; 21(2):101-110. PubMed ID: 31854268
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined effects of hepatocyte nuclear factor 4α and constitutive androstane receptor on stable warfarin doses.
    Moon JY; Lee KE; Chang BC; Jeong E; Jeong H; Gwak HS
    Pharmacogenet Genomics; 2015 Jan; 25(1):38-40. PubMed ID: 25356900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VKORC1 -1639G/A and 1173 C/T Genetic Polymorphisms Influence Individual Differences in Warfarin Maintenance Dose.
    Li Y; Zhu J; Ding J
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):488-93. PubMed ID: 26167638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function.
    Nishiba H; Nagamine A; Yashima H; Takahashi Y; Higuchi Y; Sekizaki N; Nakamura H; Araki T; Takama N; Koitabashi N; Nakajima T; Kaneko Y; Ohyama Y; Yokoyama T; Imai K; Kurabayashi M; Yamamoto K; Obayashi K
    Pharmazie; 2024 Aug; 79(7):173-177. PubMed ID: 39152554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
    Ghozlan MF; Foad DA; Darwish YW; Saad AA
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
    Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
    J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves.
    An SH; Lee KE; Chang BC; Gwak HS
    J Clin Pharm Ther; 2014 Jun; 39(3):314-8. PubMed ID: 24602049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
    Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
    Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.
    Borgiani P; Ciccacci C; Forte V; Sirianni E; Novelli L; Bramanti P; Novelli G
    Pharmacogenomics; 2009 Feb; 10(2):261-6. PubMed ID: 19207028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses.
    Yee J; Kim W; Chang BC; Chung JE; Lee KE; Gwak HS
    Cardiovasc Ther; 2019; 2019():1813747. PubMed ID: 31772606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].
    Cui GL; Ding H; Xu YJ; Chen C; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):477-81. PubMed ID: 22943641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.
    El Din MS; Amin DG; Ragab SB; Ashour EE; Mohamed MH; Mohamed AM
    Int J Lab Hematol; 2012 Oct; 34(5):517-24. PubMed ID: 22533669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction.
    Kringen MK; Haug KB; Grimholt RM; Stormo C; Narum S; Opdal MS; Fosen JT; Piehler AP; Johansen PW; Seljeflot I; Berg JP; Brørs O
    J Biomed Biotechnol; 2011; 2011():739751. PubMed ID: 21127708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.